Expert Review of Neurotherapeutics

Article	Citations
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	44
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	40
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	40
Where Art Thou O treatment for diabetic neuropathy: the sequel	38
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	33
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	32
The relevance of cortical thickness in migraine sufferers and implications to therapy	30
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	27
Advances in the treatment and management of frontotemporal dementia	26
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	26
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	25
The latest developments with internet-based psychological treatments for depression	23
Steps to manage treatment-refractory migraine in adults	23
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	23
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	23
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	22
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	22
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	22
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	22
Why is ADHD so difficult to diagnose in older adults?	21
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	21
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	21
Hesitancies in primary headaches treatments	20
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	20
Spinal automaticity of movement control and its role in recovering function after spinal injury	19

Correction	19
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	19
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?	18
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	18
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	18
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?	18
Advances in the early diagnosis of amyotrophic lateral sclerosis	18
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations	18
Virtual reality technology in the treatment of anxiety – progress and future challenges	17
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	17
Mindfulness as a therapeutic option for obsessive-compulsive disorder	17
Current use of neurotoxins for alleviating symptoms of cervical dystonia	17
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	17
Multimodal approaches to the treatment of personality disorder	16
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	16
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	16
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	16
Considerations for hormonal therapy in migraine patients: a critical review of current practice	15
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	15
The impact of sleep apnea on epilepsy treatment outcomes	15
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	15
A novel treatment option for intrajejunal levodopa administration	14
The differential diagnosis of autism spectrum disorder in adults	14
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	14
Diagnostic advances and challenges in meningioma	14
Illuminating the way: the role of bright light therapy in the treatment of depression	14
Advancements in neuroactive peptides in seizures	13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	13
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies	13
Considering hearing loss as a modifiable risk factor for dementia	13
Long-term outcomes in refractory status epilepticus	13
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	13
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes	12
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	12
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond	12
Cross-national reflections on medicinal cannabis and depression	12
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	12
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	12
Updated review of rescue treatments for seizure clusters and prolonged seizures	12
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	12
Frontotemporal dementia. How to deal with its diagnostic complexity?	12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	12
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	12
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	11
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	11
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	11
Could self-reporting sleep duration become an important tool in the prediction of dementia?	11
Therapeutic issues in Guillain–Barré syndrome	11
Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor	11

Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	11
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	10
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	10
Developments in targeting calcitonin gene-related peptide	10
Meniere disease subtyping: the direction of diagnosis and treatment in the future	10
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	10
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	10
Bipolar disorder staging and the impact it has on its management: an update	10
Novel approaches for the treatment of frontotemporal dementia: is there hope for the future?	10
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?	10
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	10
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	10
Contemporary perspectives in cerebral amyloid angiopathy	9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	9
Long-term central nervous system (CNS) consequences of COVID-19 in children	9
Rethinking the role of trazodone in the different depressive dimensions	9
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	9
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	9
Important context missing from “contemporary perspectives in cerebral amyloid angiopathy”	9
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome	9
Stem cell therapy for patients with paraplegia: is there hope for the future?	9
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	8
Contemporary diagnosis and treatment of conduct disorder in youth	8
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
Tobacco use disorder and depression: emerging strategies and recommendations:	8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	8
The challenges and opportunities related to the therapeutic use of music in psychiatry	8
Learnings in developmental and epileptic encephalopathies: what do we know?	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	8
The major challenges with pharmacologic management of chronic traumatic encephalopathy	8
Deep brain stimulation: new programming algorithms and teleprogramming	8
A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children	7
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	7
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	7
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	7
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	7
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	7
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	7
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	7
Letter to the editor: reflections on the future of medical cannabis research for depression	7
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy	7
An update on pharmacotherapy for trigeminal neuralgia	7
The value of radiotherapy in patients with recurrent atypical meningioma: an update	7
Is transcranial direct current stimulation a viable treatment option for fibromyalgia?	7
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	7
Current and emerging therapies for autoimmune encephalitis	7
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	7
What impact can brain stimulation interventions have on borderline personality disorder?	6
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	6
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	6
Mobile health technologies for the management of Parkinson’s disease	6
When is pharmacological intervention recommended for adults with social anxiety disorder?	6
The latest views on how vagus nerve stimulation works in epilepsy: a plain language summary	6
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	6
Is it possible to prevent relapse in panic disorder?	6
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	6
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	6
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	6
Precision pain management: can delta opioid receptor (DOR) agonists outperform more traditional pain management strategies?	6
Central vestibular dysfunction: don’t forget vestibular rehabilitation	6
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	6
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	6
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	6
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	6
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines	6
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	6
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	6
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	6
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	6
Paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury: the pathophysiological role of glutamate and potential treatment with branched-chain amino acids	5
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	5

Can regular physical exercise be a treatment for panic disorder? A systematic review	5
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	5
Challenges in the treatment of dysthymia: a narrative review	5
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	5
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	5
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	5
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
What is the role of placebo in neurotherapeutics?	5
Insights into headache 2022	5
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	5
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	5
Effectiveness of virtual reality rehabilitation with exergames on functional rehabilitation in Parkinson’s disease: a systematic review of chronic randomized controlled trials	5
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	5
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	5
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	5
Pharmacological options for narcolepsy: are they the way forward?	5
Assessing cognitive impairment among pediatric epilepsies: a systematic review	5
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	5
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	4
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	4
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	4
Acute and prophylactic treatment of dialysis headache: a systematic review	4
Trichotillomania and its treatment: an updated review and recommendations	4
Can pharmacotherapy help to reduce trichotillomania?	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	4
New trends in the treatment of blepharospasm: replacing the standardized approach with a personalized approach	4
The utility of magnetoencephalography in epilepsy and its implications for treatment	4
Withdrawal of antiseizure medications – for whom, when, and how?	4
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	4
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers	4
Risk factors and disease associations in people living with idiopathic intracranial hypertension	4
Evaluating clazosentan sodium for the treatment of aneurysmal subarachnoid hemorrhage	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
Rethinking the medication management of major depression	4
Current perspectives on the diagnosis and management of acute transverse myelitis	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
Redefining insomnia: from neural dysregulation to personalized therapeutics	4
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	4
Are ketamine and its enantiomers the answer to treatment-refractory depression?	4
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	3
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	3
Managing cognitive impairment in Parkinson’s disease: an update of the literature	3
Overcoming clinical challenges of refractory neuropathic pain	3
Novel techniques for early diagnosis and monitoring of Alzheimer’s disease	3
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	3
Orexins and primary headaches: an overview of the neurobiology and clinical impact	3
Personal narratives and the pursuit of purpose and possibility in psychosis: directions for developing recovery-oriented treatments	3
The management of neurofibromatosis type 1 (NF1) in children and adolescents	3
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials	3
Current perspectives on the clinical management of cryptogenic stroke	3
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis	3
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	3
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	3
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	3
Advances in the treatment of familial dysautonomia: what does the future hold?	3
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias	3
An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?	3
Suicidality and antiepileptic drugs in people with epilepsy: an update	3
Seizure medication and planned pregnancy: balancing the risks and outcomes	3
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	3
Updated strategies for the management of poor medication adherence in patients with bipolar disorder	3
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	3
Impact of psychiatric comorbidities on the treatment of epilepsies in adults	3
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	3
Current and emerging treatment options for Angelman syndrome	3
Real world considerations for newly approved CGRP receptor antagonists in migraine care	3
Essential tremor - drug treatments present and future	3
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	3
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper	3
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monothera	3
Preventing recurrence of postpartum depression by regulating sleep	3
The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications	3
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	3
Unlocking the potential of virtual reality for post-stroke sensorimotor rehabilitation - are we any closer?	3
Nanomaterials in neuromodulation: what is the potential?	3
Zonisamide oral suspension as adjunctive therapy for treating partial seizures in adults and in pediatric patients aged 16 years and older with epilepsy	3
Status epilepticus in pregnancy: a literature review and a protocol proposal	3